Amerisource Recalls Fenofibrate Capsules Due to Incorrect or Missing Labeling
Amerisource Health Services is recalling 5,034 cartons of Fenofibrate Capsules (Micronized), 200 mg, due to incorrect or missing lot and expiration dates.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The issue is a documentation/labeling error.
Plain-English summary
Amerisource Health Services is voluntarily recalling 5,034 cartons of Fenofibrate Capsules (Micronized), 200 mg, 30-count Unit Dose Blister Packs. The recall is being conducted because the product has incorrect or missing lot and/or expiration dates.
The affected product is packaged and distributed by American Health Packaging in Columbus, Ohio. The recall covers five specific lots: #142548 (Exp. 05/16), #145036 (Exp. 10/16), #151170 (Exp. 03/17), #152978 (Exp. 09/17), and #155080 (Exp. 01/18). The product was distributed nationwide.
This recall is classified as Class III by the FDA, indicating that use of or exposure to the product is not likely to cause adverse health consequences. Consumers and healthcare providers should stop using the affected product and contact their pharmacist or the recalling firm for further instructions.
The recalled product
- Product
- Fenofibrate Capsules (Micronized), 200 mg , 30-count Unit Dose Blister Packs per carton, Rx Only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 Carton of 30:NDC 68084-835-32, Individual Dose: NDC 68084-835-33.
- Manufacturer
- Amerisource Health Services
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #142548
- Exp. 05/16 Lot #145036
- Exp. 10/16 Lot #151170
- Exp. 03/17 Lot #152978
- Exp. 09/17 Lot #155080
- Exp. 01/18.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Amerisource Health Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Amerisource Health Services
See all →- HighAmerisource Recalls Paroxetine Tablets Due to Foreign Object Presence
FDA (Drugs) · 2017-11-29
- LowAmerisource Recalls Enalapril Maleate Tablets Due to Stability Failures
FDA (Drugs) · 2017-11-22
- ModerateAmerisource Recalls Glipizide Extended-Release Tablets Due to Dissolution Failure
FDA (Drugs) · 2017-03-22
- ModerateCyclosporine Capsules Recalled for Impurity Specification Failures
FDA (Drugs) · 2017-03-08
- ModerateAHP Nifedipine Capsules Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2016-11-30
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- LowAmerisource Health Services Recalls Paricalcitol Capsules Due to Impurities
FDA (Drugs) · 2016-10-19
- LowImpax Recalls Fenofibrate Capsules Due to Incorrect or Missing Labeling
FDA (Drugs) · 2016-04-20
- HighAmerisource Recalls Hydrochlorothiazide Capsules Due to Particulate Matter
FDA (Drugs) · 2016-01-20
- SevereAmerisource Health Services Recalls Mispackaged Amphetamine Extended-Release Capsules
FDA (Drugs) · 2016-09-14
- ModerateAidapak Recalls Fenofibrate Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateAmerisource Recalls Mispackaged Adderall XR 20 mg Extended-Release Capsules
FDA (Drugs) · 2016-09-14